DocumentsDate added
Review Article:
Fuyong Jiao1,*, Xiangyang Guo2, Xianpeng Yan3, Li Wei4
Affiliation:-
1Professor, Department of Pediatrics the Shaanxi Provincial People's Hospital of Xi,an Jiaotong Univeristy, Xi,an China
2Assistant Professor, Section of pediatric Neurology, Dept. of Pediatrics the Shaanxi Provincial People's Hospital of Xi,an Jiaotong Univeristy, Xi,an China
3Department of Pediatrics the Shaanxi Provincial People's Hospital of Xi,an Jiaotong Univeristy, Xi,an China
4Department of Pediatrics the Shaanxi Provincial People's Hospital of Xi,an Jiaotong Univeristy, Xi,an China
The name of the department(s) and institution(s) to which the work should be attributed:
Section of pediatric Neurology, Department of Pediatrics, 3rd affiliated hospital, Xi,an Jiaotong University, Xi,an, China
*To whom it corresponds:
Fuyong Jiao.
Prof. and Head
Dept. of Pediatrics the Shaanxi Provincial People's Hospital of Xi,an Jiaotong Univeristy, Xi,an China
President of China Society for Prevention of Child Abuse and Neglect
Executive councilor of International Society for Prevention of Child Abuse and Neglect ( ISPCAN )
Phone: ( 86) 029 -85368194, 85521331ext2361(O)
Mail Add: No.256 youyi West Rd. Xi,an 710068 China
jiaofy@yeah.net
Abstract:
Tourette syndrome is an inherited neuropsychiatric disorder with onset in childhood, characterized by multiple motor tics and at least one vocal tic. As the diagnostic threshold and assessment methodology have moved towards recognition of milder cases, the prevalence increase gradually. Males are more likely than females to express tics. The exact cause of TS is unknown, but environmental insults interact with genetic or other risk factors to engender the specificity suggested by neuropathological findings. The treatment of TS focuses on identifying and helping the individual manage the most troubling or impairing symptoms. Knowledge, education and understanding are uppermost in management plans. New studies on large prospective cohorts of patients of different age and the identification of reliable biomarkers or environmental insults are needed.
Keywords: Tourette syndrome; environmental insults; gene; supportive environment.
REFERENCES
1.Singer HS. Tourette syndrome and other tic disorders. Handb Clin Neurol. 2011;100:641–57.
2.Robertson MM.Gilles de la Tourette syndrome: the complexities of phenotype and treatment. Br J Hosp Med . 2011;72(2):100–7.
3.Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics. 1998;102 (1 Pt 1):14–19.
4.Du JC, Chiu TF, Lee KM, et al. Tourette syndrome in children: an updated review. Pediatr Neonatol. 2010 Oct;51(5):255–64.
5.Swain JE, Scahill L, Lombroso PJ, et al. Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry. 2007;46(8):947–68.
6.Scahill L, Williams S, Schwab-Stone M, et al. Disruptive behavior problems in a community sample of children with tic disorders. Adv Neurol. 2006;99:184–90.
7.Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009 Dec;67(6):497–501.
8.Bloch M, State M, Pittenger C. Recent advances in Tourette syndrome. Curr. Opin. Neurol. 2011 Apr;24(2):119–25.
9.Lombroso PJ, Scahill L. Tourette syndrome and obsessive–compulsive disorder. Brain Dev. 2008 Apr;30(4):231–37.
10.Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008 Nov;65(5):461–72.
11.Cohen DJ, Jankovic J, Goetz CG, (eds). Advances in neurology, Tourette syn58drome. Lippincott, Williams & Wilkins, Philadelphia, PA. 2001.
12.Abuzzahab FE, Anderson FO. Gilles de la TS syndrome; international registry. Minnesota Medicine. 1973 Jun;56(6):492–96.
13. Scahill L. Epidemiology of Tic Disorders. Medical Letter: 2004 Retrospective Summary of TS Literature. Tourette Syndrome Association. Thefirst page (PDF), is available at archive.org without subscription. Retrieved on June 11, 2007.
14.Zohar AH, Apter A, King RA et al. Epidemiological studies. In Leckman JF, Cohen DJ. TS Syndrome—Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. John Wiley & Sons, Inc., New York. 1999:177–92.
15.Coffey BJ, Park KS. Behavioral and emotional aspects of Tourette syndrome. Neurol Clin. 1997 May;15(2):277–89.
16.Zinner SH.Tourette disorder. Pediatr Rev. 2000;21(11):372–83.
17.Hawley, JS. Tourette Syndrome. eMedicine (June 23, 2008). Retrieved on August 10, 2009.
18.Stern JS, Burza S, Robertson MM. Gilles de la TS syndrome and its impact in the UK. Postgraduate Medicine Journal. 2005 Jan;81(951):12–19.
19.Leckman JF. TS syndrome. Lancet. 2002 Nov 16;360(9345):1577–86.
20.Denckla MB. Attention-deficit hyperactivity disorder (ADHD) comorbidity: a case for "pure" Tourette syndrome?. J Child Neurol. 2006 Aug;21(8):701–3.
21.Denckla MB. Attention deficit hyperactivity disorder: the childhood co-morbidity that most influences the disability burden in Tourette syndrome. Adv Neurol. 2006;99:17–21.
22.Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes. J Psychosom Res. 2008 Nov;65(5):473–86.
23.Walkup, JT, Mink, JW, Hollenback, PJ, (eds). Advances in Neurology, Tourette syndrome. Lippincott, Williams & Wilkins, Philadelphia, PA. 2006;99:xv.
24.O'Rourke JA, Scharf JM, Yu D, et al. The genetics of Tourette syndrome: A review. J Psychosom Res. 2009 Dec;67(6):533–545
25.Mejia NI, Jankovic J. Secondary tics and tourettism. Rev Bras Psiquiatr. 2005;27(1):11–17.
26.van de Wetering BJ, Heutink P. The genetics of the Gilles de la Tourette syndrome: a review. J Lab Clin Med. 1993 May;121(5):638–45.
27.Tourette Syndrome: Frequently Asked Questions. Tourette Syndrome Association. Retrieved on December 29, 2011.
28. Black, KJ. Tourette Syndrome and Other Tic Disorders. eMedicine (March 22, 2006). Retrieved on June 27, 2006.
29.Swerdlow, NR. Tourette Syndrome: Current Controversies and the Battlefield Landscape. Curr Neurol Neurosci Rep. 2005, 5:329–31.
30.Pauls DL, Towbin KE, Leckman JF, et al. Gilles de la TS syndrome and obsessive–compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry. 1986 Dec;43(12):1180–82.
31.Miguel EC, do Rosario-Campos MC, Shavitt RG, et al. The tic-related obsessive–compulsive disorder phenotype and treatment implications. Adv Neurol. 2001;85:43–55.
32.Peterson BS, Cohen DJ. The treatment of TS Syndrome: multimodal, developmental intervention. J Clin Psychiatry. 1998;59 Suppl 1:62–72.
33.Harris K, Singer HS. Tic disorders: neural circuits, neurochemistry, and neuroimmunology. J Child Neurol. 2006;21(8):678-89.
34.Leckman JF, Bloch MH, Smith ME, et al. Neurobiological substrates of Tourette's disorder, J Child Adolesc Psychopharmacol. 2010 ;20(4):237-47
35.Mazzone L,Yu S,Blair C,et al. An FMRI study of frontostriatal circuits during the inhibition of eye blinking in persons with Tourette syndrome. Am J Psychiatry.2010,167(3 ):341-9.
36.Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989,12(10):366-375.
37.Mink J. W. The basal ganglia and involuntary movements:Impaired inhibition of competing motor patterns. Arch. Neurol. 2003; 60,1365–1368.
38.Mink J.W. Basal ganglia dysfunction in Tourette’s syndrome:a new hypothesis. Pediatr. Neurol. 2001;25, 190–198
39.Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends Neurosci 2006; 29:175–182.
40.Stern E, Silbersweig DA, Chee KY, et al. A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 2000; 57:741–748.
41.Peterson BS, Skudlarski P, Anderson AW, et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 1998; 55:326–333.
42.Kalanithi PS, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005; 102:13307–13312.
43.Kataoka Y, Kalanithi PS, Grantz H, et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 2010; 518:277–291.
44.Leckman JF. Tourette’s syndrome. Lancet 2002; 360:1577–1586.
45.Whitaker AH, Van Rossem R, Feldman JF, et al. Psychiatric outcomes in low birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities. Arch Gen Psychiatry 1997; 54:847–856.
46.Mathews CA, Bimson B, Lowe TL, et al. Association between maternal smoking and increased symptom severity in Tourette’s syndrome. Am J Psychiatry 2006; 163:1066–1073.
47.Fagel DM, Ganat Y, Cheng E, et al. Fgfr1 is required for cortical regeneration and repair after perinatal hypoxia. J Neurosci 2009; 29:1202–1211.
48.Singer HS. Tourette’s syndrome: from behaviour to biology. Lancet Neurol 2005; 4:149–159.
49.Threlfell S, Clements MA, Khodai T, et al. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 2010; 30:3398–3408.
50.Morris G, Arkadir D, Nevet A, et al. Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 2004; 43:133–143.
51.Price RA, Kidd KK, Cohen DJ, et al. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985; 42:815–820.
52.Walkup JT, LaBuda MC, Singer HS, et al. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 1996; 59:684–693.
53.Kurlan R, Eapen V, Stern J, et al. Bilineal transmission in Tourette’s syndrome families. Neurology 1994; 44:2336–2342.
54.Hasstedt SJ, Leppert M, Filloux F, et al. Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J HumGenet 1995; 57:682–689.
55.Sundaram SK, Huq AM, Wilson BJ, Chugani HT. Tourette syndrome is associated with recurrent exonic copy number variants. Neurology 2010; 74:1583–1590.
56.Verkerk AJ, Mathews CA, Joosse M, et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003; 82:1–9.
57.Lawson-Yuen A, Saldivar JS, Sommer S, Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 2008; 16:614–618.
58.Ercan-Sencicek AG, Stillman AA, Ghosh AK, et al. L-histidine decarboxylase and Tourette’s syndrome. N Engl J Med 2010; 362:1901–1908.60 Leckman JF, Bloch MH, King RA, et al."Phenomenology of tics and natural history of tic disorders. Adv Neurol. 2006;99:1–16.
59.Leckman JF, Bloch MH, King RA, et al."Phenomenology of tics and natural history of tic disorders. Adv Neurol. 2006;99:1–16.61
60.Bagheri MM, Kerbeshian J, Burd L. Recognition and management of TS syndrome and tic disorders. American Family Physician. 1999; 59:2263–74.
61.The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol. 1993 Oct;50(10):1013–16.
62.Dure LS 4th, DeWolfe J. Treatment of tics. Adv Neurol. 2006;99:191–96.
63.Malone DA Jr, Pandya MM. Behavioral neurosurgery. Adv Neurol. 2006;99:241–47.
64.Jankovic J. Differential diagnosis and etiology of tics. Adv Neurol. 2001;85:15–29.
65.Cohen AJ, Leckman JF. Sensory phenomena associated with Gilles de la TS syndrome. J Clin Psychiatry. 1992 Sep; 53(9):319–23.
66.Prado HS, Rosário MC, Lee J, et al. Sensory phenomena in obsessive–compulsive disorder and tic disorders: a review of the literature. CNS Spectr. 2008;13(5):425–32.
67.Bliss J. Sensory experiences of Gilles de la Tourette syndrome.Arch Gen Psychiatry. 1980 Dec; 37(12):1343–47.
68.Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in TS syndrome.Mov Disord. 2003 Dec;18(12):1530–33.
69.Scahill LD, Leckman JF, Marek KL. Sensory phenomena in TS syndrome. Adv Neurol.1995; 65:273–80.
70.Miguel EC, do Rosario-Campos MC, Prado HS, et al. Sensory phenomena in obsessive–compulsive disorder and TS disorder. J Clin Psychiatry. 2000 Feb;61(2):150–56.
71.Rapin I. Autism spectrum disorders: relevance to Tourette syndrome. Adv Neurol. 2001;85:89–101.
72.Spencer T, Biederman J, Harding M, et al. Disentangling the overlap between TS disorder and ADHD". J Child Psychol Psychiatry. 1998 Oct;39(7):1037–44.
73.Summary of Practice: Relevant changes to DSM-IV-TR. American Psychiatric Association. Retrieved from May 11, 2008
74.Scahill L, Erenberg G, Berlin CM Jr, et al. Tourette Syndrome Association Medical Advisory Board: Practice Committee. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx. 2006 Apr;3(2):192–206.
75.Ringman JM, Jankovic J. Occurrence of tics in Asperger's syndrome and autistic disorder. J Child Neurol. 2000 Jun;15(6):394–400.
76.Jankovic J, Mejia NI. Tics associated with other disorders. Adv Neurol. 2006;99:61–68.
77.Freeman, RD. TS Syndrome: minimizing confusion. Roger Freeman, MD, blog. Retrieved on February 8, 2006.
78.Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000;123 Pt 3:425–62.
79.Schapiro NA. Dude, you don't have TS: TS syndrome, beyond the tics. Pediatr Nurs. 2002; 28(3):243–46, 249–53.
80.Coffey BJ, Shechter RL. Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders. Adv Neurol. 2006; 99:208–21.
81.Himle MB, Woods DW, Piacentini JC. et al. Brief review of habit reversal training for tourette syndrome. J Child Neurol. 2006 Aug;21(8):719–25.
82.Woods DW, Himle MB, Conelea CA. Behavior therapy: other interventions for tic disorders. Adv Neurol. 2006; 99:234–40.
83.Pappert EJ, Goetz CG, Louis ED, et al. Objective assessments of longitudinal outcome in Gilles de la TS syndrome. Neurology. 2003 Oct 14;61(7):936–40.
84.Singer HS. TS syndrome: from behaviour to biology. Lancet Neurol. 2005 Mar;4(3):149–59.
85.Burd L, Kerbeshian PJ, Barth A, et al. Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome. J Child Neurol. 2001;16(6):431–37.
86.Leckman JF, Cohen DJ. TS Syndrome—Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. John Wiley & Sons, Inc., New York. 1999:37.
87.Cohen DJ, Leckman JF, Pauls D. Neuropsychiatric disorders of childhood: TS syndrome as a model. Acta Paediatr Suppl 1997,422; 106–11.
88.Fuyong Jiao ,Xianpeng Yan ,Ru Xue, Jing Lin,Tourette treatment progress .China Medicine and Pharmacy. 2012;2 (23):52-54.
89.Fuyong Jiao,Li Wei,Jing Lin et al. Clincal assessment of treatment of Tourette Syndrome in Chinese children with Clonidine transdermal patch , Journal of the Polish society of Child Neurology ,2011;20 (40):15-19, 20.
90.Ya-song Du, Hua-fang Li, Alasdair Vance, Fu-yong Jiao et al .Randomized double-blind multicentre placebo-controlled clinical trial of the Clonidine adhesive patch for the treatment of tic disorders, Australian and New Zealand Journal of Psychiatry 2008; 42:807-813.
Article citation:
Jiao Fuyong,Guo Xiangyang,Yan Xianpeng,Wei Li. Update situation of Tourette syndrome. J Pharm Biomed Sci 2014; 04(04): 327-337. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Jiao Fuyong,Guo Xiangyang,Yan Xianpeng,Wei Li. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original article
Khetri R1,*, Dugar D2, Tim H T3
Affiliation:-
1Associate professor, 2Assistant professor, 3 2nd year P.G Student, Department of General surgery, Hi-Tech Medical college and Hospital, Bhubaneswar, Odisha, India
The name of the department(s) and institution(s) to which the work should be attributed:
Department of General surgery, Hi-Tech Medical College and Hospital, Bhubaneswar, Odisha, India
*To whom it corresponds:
Dr. DHARMENDRA DUGAR.
Assistant professor,
Department of surgery, Hi Tech Medical College & hospital; Bhubaneswar, Odisha, India
Mobile no.09437091846
Abstract:
Background: Little efforts have been done to know if Background: Health care associated infections are frequent in surgical wards and represent a high burden on patients and hospital in terms of morbidity, mortality, prolonged length of hospital stay and additional costs. In this study we analyse organism found at incision site intraoperatively and its relation with post-operative wound infection.
Material & method: We conducted a prospective hospital based study of 114 patients who underwent elective surgery. Patients were selected considering the inclusion and exclusion criteria. Two groups were considered–clean wounds (Group A) and clean contaminated wounds (Group B). Samples were taken from two sites–operative field and subcutaneous plane. Post-operative samples were collected from wound showing signs of infection.
Results: Most common organism grown in Group A in decreasing order was Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella and E. coli. Group B has Staphylococcus aureus, E. coli being the most common followed by Pseudomonas aeruginosa, Klebsiella. In post-operative period 4 patients from Group A and the same number of patients in Group B had serous/ purulent discharge. Out of 8/114 cases of surgical site infections only once the intra-operative site organism and post-procedure infection site organism was found to be same.
Conclusion: Although endogenous bacteria is responsible in most cases of SSI but intra-operative surgical site bacteria and post-operative SSI culture may be different. Hence taking suture site swab for culture in all surgical patients is not recommended for clean or clean contaminated wounds.
Keywords: Surgical Site Infection [SSI];Centres of Disease Control and prevention (CDC);Methicillin Resistant Staphylococcus Aureus [MRSA].
REFERENCES
1.Nichols RL. Post operative infections in the age of drug- resistant gram-positive bacteria. Am J Med. 1998;104:11S-16S.
2.Mshana SE, Kamugisha E, Mirambo M, Chakraborty T, Lyamuya EF. Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. BMC Res Notes. 2009 Mar 26;2:49.doi:10.1186/1756-0500-2-49.
3.Levy, S.B. (1998). The challenge of antibiotic resistance. Scientific American 278, 46-53
4.Larson E Community factors in the development of antibiotic resistance. Annu Rev Public Health. 2007;28:435-47.
5.Rao GG Risk factors for the spread of antibiotic- resistant bacteria. Drugs. 1998 Mar; 55(3):323-30.
6.Wong ES. Surgical site infection. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. Philadelphia: Lippincott Williams & Wilkins; 2004.p.287-310.
7.Sehulster L, Chinn RYW. Guidelines for environmental infection control in healthcare facilities. MMWR.2003;52(RR10):1-42.
8.Streifel AJ. Design and maintenance of hospital ventilation systems and the prevention of airborne nosocomial infections. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. Baltimore: Williams & Wilkins; 2004:1577-1589.
9.A Ramesh, R Dharini. Surgical site infections in a teaching hospital. Clinico-microbiological and Epidemiological Profile, VMMCH, Puducherry. Int J Biol Med Res.2012; 3(3); 2050-2053.
10.SP Lilani, N Jangale, A Chowdhary, GB Daver. Surgical site infection in clean and clean-contaminated cases. 2005; 23(4): 249-252.
11.JyotiSonawane, N Kamath, Swaminathan, Bacteriological Profile and their Antibiogram in a tertiary hospital in Mumbai, Bombay Hospital Journal. 2010; 52(3): 358-361.
12.Rasnake MS., Dooley DP. Culture-negative surgical site infections. Surg Infect (Larchmt). 2006 Dec; 7(6):555-65.
Article citation:
Khetri R, Dugar D, Tim HT. Surgical site infection and its relation to Intra operative suture site organisms. J Pharm Biomed Sci 2014; 04(04): 338-342. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Original article
Niraj K Biswas1,*,Parimal H Patel2,Suresh Narayan Sharma3,Shankar Prakash4
Affiliation:-
1Assocaite professor,2Assistant Professor, Microbiology, GMERS Medical college, Valsad, Gujarat, India
3Professor,4Professor and HOD, Microbiology, PMCH, Patna, Bihar India
The name of the department(s) and institution(s) to which the work should be attributed:
1.GMERS Medical college, Valsad, Gujarat, India
2.PMCH, Patna, Bihar India
*To whom it corresponds:-
Dr Niraj K Biswas
Department of Microbiology, GMERS Medical college, Valsad, Gujarat, India
Contact no:+91-8758607152
Abstract:
Diarrhoeal diseases are a global public health problem causing considerable morbidity and mortality among infants and children especially in the developing countries. From the bacterial pathogen E.coli is constantly associated with it worldwide. Aim of the study to know prevalence of bacterial pathogen in diarrhoea in patients up to three year of age.
Materials and Methods: In duration of six month (Jan–June 2004) stool samples were collected from patients (up to 3 years of age) of diarrhoea and proceed by standard conventional method. Serological identification of isolated strains of E.Coli done at Central Research Institute Kasauli.
Results: stool samples of 125 patients were collected , in which male were more affected. E.coli isolated in 70.4% cases followed by Klebsiella sp., proteus sp., pseudomonas sp., shigella sp. and staphylococcus sp.. Isolated E.coli were of different serotype.
Conclusion: E. coli was predominant organism isolated. Serotype 055:B5 is commonest followed by 0127:B8 serotype in diarrhoea caused by E.coli.
Keywords: Diarrhoea, E.coli, serotype.
REFERENCES
1.Kamath KR. Fieldman RA. Sunder Rao, P SS & Webb, J.K.G. Infection and disease in group of south Indian families II General morbidity pattern in families and family member. Am.j of Epidemiology 89:375-383,1969.
2.Jadhav M. Report of work done on an investigation of diarhoea in infants and children ant CMC Vellore, ICMR 1965, New Delhi.
3.Kale VV, Lakshmi Iyer, & Jain MK. Shigellosis in infants and children J. Post.Grad. Med. Oct 1982; 28(4): 206-209,
4.Paveri KM. Infantile diarrhoea. Ind.J. Child health. 1952;1:418.
5.Sood S. Ind.J. Child health, 12:727,1963.
6.Sharma, S.K. Talija , R.K. Manjrekar, P.S. and Kant K.W. Ind. Paed. 1967;5:154-160.
7.Bhat PP & Mayers RM. Ind.J.Micro 1961;1:17.
8.Naruka,B.S Sharma,U. saxena,S.Aggarwal,S.S.& Sharma,M.L. Ind J.Path & Bact.Vol.13,No-6,451-455,1976.
9.Ordway NK. But Org. Mond. Sante, Bull. WHO 23: 73-101,1960.
10.Pande,R.C ,Rajvanshi, V.S and Malhotra,TN. Ind J. Path & Bact. Jan 1973;16:31.
11.Naidu,L: Study of infantile diarrhoea. Ind.J.Med.Res. 1962;50:613.
12.Tazir MA, Shrivastava KK, Khannisa SK, Aggrawal RC, Clinico-Bacteriological study of acute Gastroenteritis. Ind.J of Patho & Micro. Dec1978;85.
13.Behera SK, Mahapatra. Bacteriological study of diarrhoea in infants & childhood Ind.Paed. 1979;16:5.
14.Nath P,Bajpai PC. Amanullah, Khan AM. Ind.J.Path and Bact.1973; 16:37-41.
15.Shrivastava JR, Verma B,Garg BK. Acute diarrhoea in childhood. A clinical and bacteriological study. Ind.J.of Paed. 1968;35:217.
16.Basu B, Bhattacharya SR. Enterotoxigenicity and serotyping of E.Coli isolated from infantile gastroenteritis pt in Pune. Ind.J. Med. Res. 1983;Dec 78: 19-21.
17.Joseph Theresa. Bacteriology of diarrhoea in infants and children.Ind.J. of Micro. July-Sep.1980;20:3.
18.Sen Gupta SR,Sharma KD. Ind .J. Path and Bact. 1967;10:304.
19.Pande RC. Bacteriology of infantile diarrhoea and Gastroenteritis in Allahabad. Ind.J.Path & Micro. 1976;19:169.
20.Manorma Dev, Bhagwala R.A, Shriniwas & Singh,Maherbhan.Klebsiella pneumonia as the possible cause of an outbreak of diarrhoea in a neonatal special care unit. Ind.J.Med. March 1980;Res.71:359-362.
21.Arora MM, Pohowalla JN. Diarrhoea in infancy and childhood, Ind.J.Child Health. 1955;4:559.
22.Romas Alvarez M and Olate J, Diarrhoeal disease of children. The occurrence of enteropathogenic viruses and bacteria.Amer.J.Dis.child 1964;107:218.
23.Dmitrieva N, Zakaryan L.M. Staphylococcus in intestinal infection in infants.Abstracted in Excepta Medica (Paed), 1964;18:777.
24.Manchanda SS, Arora NN. Acute gastroenteritis in infants and young children with special reference to some etiological factors. Ind.J.Paed.1958;25:539.
25.Ahmed R, Bopp C. Phage typing scheme for Esch. Coli 0157:H7. J.Infect.Dis. 1987;155:806-809.
Article citation:
Biswas NK,Patel PH,Sharma NS,Prakash S. Study of prevalence of Bacterial pathogen as causative agent of diarrhoea in 0-3 years patients attending a Tertiary care Hospital Patna, Bihar,India. J Pharm Biomed Sci 2014; 04(03): 371-374. Available at www.jpbms.info.
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Original article:
Trivedi Grishma1,*, Nerurkar Alka B2
Affiliation:-
1Assistant Professor, 2Professor & Head, Microbiology Department, GMERS Medical College & Hospital, Valsad, Gujarat, India.
The name of the department(s) and institution(s) to which the work should be attributed:
Microbiology Department, GMERS Medical College& Hospital, Valsad, Gujarat, India
*To whom it corresponds:-
Dr. Grishma Trivedi.
Assistant Professor, Department of Microbiology, GMERS Medical College & Hospital, Valsad, Gujarat, India.
Email: drgrtrivedi@gmail.com
Abstract:
Introduction: HIV infection is a global epidemic. In India, HIV was first detected in commercial sex workers in Tamil Nadu in 1986 and since then, the infection is growing quite fast with geographic variation. The epidemiology of HIV in rural India is not well known and rural residents have been underrepresented, despite 67% of HIV infected people live in rural areas.
Aim: To find out the sero-prevalence of HIV infection in a rural tertiary care teaching hospital.
Material & Method: A retrospective analysis was carried out, of 3802 participants enrolled at Integrated Counseling and Testing Center (ICTC) attached to our tertiary care teaching hospital. HIV sero-positive participants were further analysed on the basis of age, sex and possible routes of transmission.
Results: Out of 3802, 1909 (50.21%) were males, 1887 (49.63%) were females and 06 (0.16%) were Trans-sexual/Transgender (TS/TG). Amongst the total of 3802 participants, 175 (4.6%) were proved to be positive for HIV-1 infection. Prevalence of HIV infection among males was 104 (5.45%), females was 67 (3.55%) and TS/TG was 4 (66.7%); while the most common transmission route was heterosexual (n=158, 90.3%), followed by vertical (n=15, 8.6%) and homosexual/Bisexual (n=2, 1.14 %).
Conclusion: More studies are required for population residing in rural areas as HIV epidemic appears to be moving from urban to rural populations..
Keywords: HIV; Rural tertiary care hospital; Sero-prevalence; Trans-sexual/Transgender population.
REFERENCES
1.Fauci AS, Lane HC. Human immunodeficiency virus disease: AIDS and related disorders. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison's Principles of Internal Medicine, 18th ed. USA: The McGraw-Hill companies, Inc., 2012; pg:1506-1587.
2.AIDS epidemic, 2006: AIDS epidemic update 2007. (Online) Cited 2009 April). Available from URL:http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdfg.
3.Godbole S, Mehendale S. HIV/AIDS epidemic in India: risk factors, risk behavior & Strategies for prevention & control. Ind J Med Res 121, April 2005, pp 356-368.
4.National AIDS Control Organization. Ministry of Health & Family Welfare, Government of India. HIV Sentinel Surveillance 2006 India Country Report. Available from: http://www.nacoonline.org/Quick_Links/Publication/ME_and_Research_Surveillance/Reports_and_Surveys/HIV_Sentinel_Surveillance_2006_India_Country_Report/
5.NACO (2007) Guidelines on HIV Testing. National AIDS Control Organisation Available: http://www.nacoonline.org/upload/Final%20Publications/Blood%20Safety/GUILDELINES%20FOR%20HIV%20TESTING.pdf. Accessed 12 December 2013.
6.Mir MA et al. Clinical and demographic profile of HIV/AIDS patients diagnosed at a tertiary care center in Kashmir. J Pak Med Assoc June 2010; Vol. 60, pg:428-431.
7.Gerardo Alvarez-Uria et al. Gender differences, routes of transmission, socio-demopgraphic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infectious Disease Reports 2012; Volume 4:e19, pg 66-70.
8.Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-9.
9.May M, Gomples M, Delpech V, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011;343.
10.Vyas KJ et al. A comparison in HIV-associated stigma among healthcare workers in urban and rural Gujarat. Journal of Social Aspects of HIV/AIDS; Vol. 7, Iss. 2 August, 2010; pg:71-75
11.Abdul Karim Q, Abdool Karim SS, Singh B, Short R, Ngxongo S. Sero-prevalence of HIV infection in rural South Africa. AIDS; 1992 Dec; 6(12):1535-9.
12.Sekar et al. Recent trends in HIV prevalence in a remote setting of southern India: Insights into arranging HIV control policies.
13.Asia Pacific Coalition on Male Sexual Health (APOCOM), Mapping Transgender Groups, Organisation & Networks in South Asia, 2008; Available at http://www.msmasia.org.
14.WHO, Prevention and Treatment of HIV & Other Sexually Transmitted Infections Among Men Who Have Sex With Men & Transgender People:Recommendations for a Public Health Approach, June 2011; Available at http://www.who.int/hiv/pub/guidelines/msmguidelines2011/en/index.html, P.10.
15.HIV & Transgendered/Transexual Communities; Integragency Coalition on AIDS & Development, August 2011; Available at http://icad-cisd.com.
16.UNAIDS/WHO. Country Progress Report. UNGASS. India, March 2010. Available from: http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010progressreportssubmittedbycountries/india_2010_country_progess_report_en.pdf
17.Vlassoff C, Weiss MG, Rao S, Ali F, Prentice T. HIV-related stigma in rural and tribal communities of Maharashtra, India.
Article citation:
Trivedi Grishma, Nerurkar AB. Seroprevalence of HIV infection in a rural tertiary care teaching hospital of South Gujarat from January To December 2012. J Pharm Biomed Sci 2014;04(04):356-360.Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Trivedi Grishma, Nerurkar AB. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Research article
R. Sangeetha Kumari1,*, V.Kaviyarasan2
Affiliation:-
1Research Scholar, 2Assistant Professor, CAS in Botany, University of Madras, Guindy campus, Chennai –600025,India
2Assistant Professor,CAS in Botany, University of Madras, Guindy campus, Chennai – 600 025.
The name of the department(s) and institution(s) to which the work should be attributed:
CAS in Botany, University of Madras, Guindy campus, Chennai –600025, India
*To whom it corresponds:-
R. Sangeetha Kumari.
Research Scholar, CAS in Botany, University of Madras, Guindy campus, Chennai –600025, India
Email: sangkumari@gmail.com, Ph: +919092875300
Abstract
The siderophores produced by fungal organisms were screened from the both culture supernatants and solid medium by the universal chrome assural assay (CAS assay). All the screened organisms are comes under the hydroxymate type of siderophores using Iron Percholate assay at 480nm. The effect of iron concentration and complexity of media has been studied for siderophore production in the edible and medicinal mushrooms Agaricus sp and Lentinus sp. The siderophore coding genes were studied using random amplification with P1 and P2 primers.
Keywords: Chrome Azurol Sulphonate (CAS); deferroxamine; hydroxymate; carboxylate; catecholates; basidiomycetes.
REFERENCES
1.D. B. Alexander, D. A. Zuberer. Use of chrome azurol S reagents to evaluate siderophore production by rhizosphere bacteria. Biology and Fertility of Soils. 1991;12: 39-45.
2.Arnow LE. Colorimetric determination of the components of 3,4-dihydroxyphenylalanine-tyrosine mixtures. J. Biol.Chem. 1937; 118:531-537.
3.Atkin CL, Neiland JB, Phaff HJ. Rhodotorulic acid from species of Leucosporidium, Rhodospondium, Rhodotorula, Sporidiobolus and Sporobolomyces, and a new alanine- containing ferrichrome from Cryptococcus meliviosu.ni. J Bacteriol. 1970; 103:722-73
4.A.L. Crumbliss,. Aqueous Solution Equilibrium and Kinetic Studies of Iron Siderophore and Model Siderophore Complexes, Handbook of Microbial Iron Chelates, G. Winkelmann, Ed., CRC Press, 1991, Chap. 7. (invited).
5.Baakza A, Vala AK, Dave BP, et al. A comparative study of siderophore production by fungi from marine and terrestrial habitats. J. Exp. Mar. Biol. Ecol. 2004; 311:1–9.
6.S. Dhungana & A.L. Crumbliss. Coordination chemistry and redox processes in siderophore-mediated iron transport. Geomicrobiology. Journal, 2005;22:87-98.
7.Fekete, F.V. Chandhoke and J. Jellison. Iron binding compounds produced by wood decaying basidiomycetes. Appl.Environ.Microbiol.1989; 55:2720-2722.
8.Frey-Klett, P., Chavatte, M, Clausse, M.L., Courrier, S, Le Roux, C, Raaijmakers, J, Martinotti, M.G., Pierrat, J.C. and Garbaye, J. Ectomycorrhizal symbiosis affects functional diversity of rhizosphere fluorescent pseudomonads. New phytologist. 2005; 165: 317-328.
9.Hu, C. J., C. Bai, X. D. Zheng, Y. M. Wang, and Y. Wang. Characterization and functional analysis of the siderophore-iron transporter CaArn1p in Candida albicans. J. Biol. Chem. 2002;277:30598–30605.
10.Ismail A, Bedell GW, Lupan DM. Siderophore production by the pathogenic yeast Candida albicans. Biochem Biophys Res Comm.1985; 130:885–891.
11.Jelliso, J., B. Goodell, F.Fekete and V. Chandhoke, 1990. Fungal siderophores and their role in wood degradation. International Research group on wood preservation DOC.NO.IRG/WP/1442. IRG Secretariat, Stockholm, Sweden. 16PP.
12.Martin JD, Ito Y, Homann VV, et al. Structure and membrane affinity of new amphiphilic siderophores produced by Ochrobactrum sp. SP18. J Biol Inorg Chem. 2006;11:633–641. [PubMed]
13.Oberegger, H., M. Schoeser, I. Zadra, B. Abt, and H. Haas. SREA is involved in regulation of siderophore biosynthesis, utilization and uptake in Aspergillus nidulans. Mol. Microbiol. 2001; 41:1077–1089.
14.Reigh Geraldine, 1991. Analysis of siderophore production by Rhizobium meliloti 220-5. PhD thesis, Dublin City University.
15.Renshaw JC, Robson GD, Trinci APJ, et al. Fungal siderophores: structures, functions and applications. Mycol. Res. 2002;106:1123–1142.
16.Santose, R., N. Buisson, S. Knight, A. Dancis, J.M. Camadro, and E. Lesuisse. Haemin uptake and use as an iron source by Candida albicans: role of CaHMXI encoded haem oxygenase. Microbiology. 2003;149: 579-588.
17.Schroder, I., E. Johnson, and S.de Vries. Microbial ferric iron reductases. FEMS Microbiol. Rev.2003; 27:427–447.
18.Schwyn, B., and Neilands, J.B. Universal chemical assay for the detection and determination of siderophores. Anal Biochem. 1987; 160:47-56.
19.Steglich W, Steffan B, Stroech K, Wolf M. Pistillarin. A characteristic metabolite of Clavariadelphus pistillaris and several Ramaria species (Basidiomycetes) Z Naturforschung, C. 1984; 39C:10–12.
20.Winkelmann G. Microbial siderophore-mediated transport. Biochem Soc Trans. 2002; 30(4):691-6.
Article citation:
Sangeetha RK, Kaviyarasan V. Screening of Siderophores in Basidiomycetes. J Pharm Biomed Sci 2014; 04(04): 291-297. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.